Join us for the inaugural HAPI Hour Seminar with Carl Elliott MD, PhD. In his talk titled "Cops and the K-Hole: The Hennepin Healthcare Forced Ketamine Studies," Dr. Elliott will present his researc...

Under investor pressure, Novo presented its strategy to both grow its obesity franchise and diversify its pipeline.

It's not hard to explain why business is booming for telehealth companies. The apps and websites offer quick, convenient access to prescriptions for sensitive medical conditions, including weight loss...

To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overd...

It’s legal to pay practising physicians to promote specific drugs — and thousands are doing so.

There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean doctors have reconsidered.

Background The 21st Century Cures Act (2017) was enacted during a period of evolving FDA flexibility in evidentiary standards for drug approval. To examine trends before and after implementation, we i...

Want to halt aging, stop divorce and increase national security? The Trump administration seems to believe hormones can do all of that.

Opioid settlement cash was meant to abate the addiction crisis. But a new investigation reveals millions in Louisiana was spent on law enforcement gear and police technology instead of lifesaving trea...

Several of those escorted out were scheduled to present at the American Diabetes Association conference this weekend.

Vaginal estrogen has been used for menopausal vaginal symptoms. Estrogen has been prescribed to prevent urinary tract infection, based in part on the belief that estrogen is effective and without adve...

Results of a new study

Are too many symptoms blamed on perimenopause? Two experts weigh in on the “First Opinion Podcast.”

All subgroups of patients with antihypertensive prescriptions had an increased risk of hospitalisation or death due to falls versus those who were unexposed. No significant difference in risk of falls...

Dr Kenny Lin reviews the updated ACC/AHA dyslipidemia guidelines and explains why primary care clinicians shouldn't blindly accept the new rules as gospel.

Drugmakers, influencers, and industry-funded advocacy groups are pushing Alzheimer’s screenings that could label millions of Americans as sick — despite shaky science and dangerous treatments.

As the Sackler family worked through a plan to pay $6.5 billion to resolve their liability over Purdue Pharma LP’s production of addictive opioids, the epidemic hit even closer to home.

The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before release.

GLP-1 overdoses are on the rise, and some clinicians suggest informing patients of the risk in the initial consultation.

With Health Secretary Robert F. Kennedy Jr. aiming to rein in the use of psychiatric drugs, psychiatrists are preemptively addressing how and when patients should quit taking them.

Redefining Pain and Addiction: How Opioid Manufacturers Changed Medical Language to Foster Opioid Use

Aging is associated with varying symptoms that pharmaceutical companies have been quick to medicalize, defining natural processes in disease terms to prepare th

This study assesses national trends in the prevalence of long-term opioid therapy and the characteristics of patients using data from a longitudinal prescription database containing prescriptions from...

The recent explosion of perimenopause attention tells women that they are controlled by their hormones.

The Food and Drug Administration relies on advisory committees for independent advice on developing and evaluating drugs and other products. If...

This systematic scoping review examines the existing research on social media influencer promotion of prescription drugs and identifies recurring themes, gaps in regulatory oversight, and opportunitie...

Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found batteries with an “extremely high failure rate.”

A new bill introduced in the Maryland House of Delegates requests that pharmas be more specific about the brands related to their otherwise unbranded disease awareness initiatives. | A new bill introd...

A bill introduced in the Maryland legislature would require drugmakers to disclose ties to disease awareness campaigns.

Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD. The approval process took o …

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

On this page you'll find information on:

The opioid epidemic is a serious crisis in the United States. It has been proposed that opioid prescriptions following dental procedures are a major contributor to opioid use and abuse. The American D...

Uninformed influencers and physicians peddling menopausal hormones are in desperate need of a history lesson.

Allegations a scientist doctored images in a paper on Alzheimer’s. Rachel Hardeman's resignation. An investigation into a pediatrician's reports of child abuse. The U saw a number of scientific scanda...

Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some forms of hormone therapy used to treat the symptoms of menopause. But in ma...

No new data supports these label changes, which fly in the face of known science. More than 100,000 women in Kansas City and 670,000 in Kansas are affected. | Opinion

The removal of a warning label on menopausal hormone therapies has been hailed as a win for a US advocacy campaign. But the origins of that campaign suggest industry is laying the groundwork for a wid...

This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with...

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics.

As leading drugmakers launch direct-to-patient platforms with steep discounts and digital care bundles, a new channel dynamic is emerging that gives manufacturers greater control of patient engagement...

Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been studied closely. ‘I was living in a body hijacked by the medication.’

The country’s top pharmaceutical lobbying group secretly gave millions to a Republican-aligned dark money group, then won billions in drug-pricing exemptions.